Queen’s University Belfast team makes a massive colon cancer breakthrough

New findings emerging from the research team at Queen’s University Belfast have identified a cellular process which can be exploited in order to kill BRAF mutant colon cancer cells, a particularly aggressive subgroup of colon cancers. These cancers are not only extremely aggressive but they do not respond well to conventional cancer treatments.

The QUB team behind the discovery describe it as a “ground-breaking therapeutic process that can target and kill bowel cancer cells”. The treatment will be a key tool in tackling the most aggressive form of the illness which conventional treatments have little or no impact on. The revolutionary technique may improve survival rates for colon cancer patients globally.

Professor Sandra Van Schaeybroeck, remarked: “This research is good news for bowel cancer patients as further clinical trials investigating the effect of such agents could improve the survival outcome of patients in Northern Ireland and beyond.”

Congratulations to all researchers involved!

Here is some digital press coverage of this story:

https://www.thetimes.co.uk/article/belfast-team-discover-way-to-target-bowel-cancer-cells-thxqltfqw

https://www.irishtimes.com/news/health/bowel-cancer-breakthrough-discovered-at-queen-s-university-belfast-1.3619261

https://www.rte.ie/news/2018/0906/991937-qub_bowel_cancer/

https://www.bbc.co.uk/news/uk-northern-ireland-45431053

http://www.dailymail.co.uk/wires/pa/article-6136787/New-bowel-cancer-treatment-improve-survival-rates.html?ns_mchannel=rss&ito=1490&ns_campaign=1490

http://www.oxfordtimes.co.uk/news/national/16691154.new-bowel-cancer-treatment-may-improve-survival-rates/

Belfast Telegraph

The Daily Mirror

The Newsletter

MErCuRIC explainer video is launched

The MErCuRIC three-minute explainer video was launched on 21 May 2018.

Please watch, utilize and share it!

 

‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success Story

MErCuRIC was featured as a Horizon 2020 Success Story on the European Commission’s Policies, information and services webpage on April 14, 2018. Below is an excerpt from the story.

“Made-to-measure treatments are becoming possible because of the growing understanding of the genetic and molecular nature of cancers and disease in general,” says Coordinator Sandra Van Schaeybroeck of Queen’s University Belfast. As well as offering welcome benefits to future colorectal cancer sufferers, MErCuRIC is an example of where medical treatment is heading.

“MERCURIC focuses on a particular sub-group of CRC patients. However, this ‘stratified’ approach beginning with a genetic and molecular profile of a patient can, and is, increasingly applied to many cancers and other disease groups.”

Read the entire story here.

MErCuRIC Europa-Research&Innovation

Promotional Material now available in our Media Area

We have new promotional material now available to view in our media area. Follow this link to view our latest flyer.

MErCuRIC UTV Segment

The MerCuRIC project was covered on UTV television’s UTV Live News programme and website on 11 December, including an interview with Prof Mark Lawler of QUB.

Full Article Here: http://www.u.tv/News/Queens-announces-major-cancer-study/7ccf6333-ea82-432f-ad13-6fb84aa0931f

New Website Launched

Thank you very much for visiting our new website for the MErCuRIC project.

We’ll be updating the site over the next few weeks.